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Abstract
Background—To assess factors associated with having a Trichomonas vaginalis (TV) infection
among persons receiving care for HIV and estimate the number of transmitted HIV infections
attributable to TV.
Methods—HIV clinic patients were recruited from two secondary prevention studies, screened
by urine nucleic-acid amplification tests for sexually transmitted infections (STIs) and interviewed
about risk factors (baseline, 6 and 12 months). We conducted mathematical modeling of the
results to estimate the number of transmitted HIV infections attributable to TV among a cohort of
HIV-infected patients receiving medical care in North Carolina.
Results—TV was prevalent in 7.4%, and incident in 2% – 3% of subjects at follow-up.
Individuals with HIV RNA less than 400 copies/ml (OR 0.32, 95% CI: 0.14 – 0.73) and at least 13
years of education (OR 0.24, 95% CI: 0.08 –0.70) were less likely to have TV. Mathematical
modeling predicted that 0.062 HIV transmission events occur per 100 HIV infected women in the
absence of TV infection and 0.076 HIV infections per 100 HIV and TV-infected women (estimate
Corresponding Author/Request for reprints: E. Byrd Quinlivan, MD; 130 Mason Farm Road; UNC-CH, Campus Box 7030, Chapel
Hill, NC, 27599-7030; Phone: (919) 966-2536; Fax: (919) 966-6714; ebq@unc.edu.
Changed Addresses (current): Shilpa Patel: Department of Behavioral Sciences and Health Education, Emory University, Atlanta,
GA. H-C. Tien: Frank Port Graham Child Development Institute, University of North Carolina-Chapel Hill, Chapel Hill, NC.
Potential conflict of interest. E. Byrd Quinlivan, Shilpa Patel, Catherine A. Grodensky, Carol E. Golin, Hsiao-Chuan Tien, and
Marcia M. Hobbs: no conflict.
Meeting presentations: This work has not been presented at any conferences.




Sex Transm Dis. Author manuscript; available in PMC 2013 September 01.
Published in final edited form as:













range: 0.070 – 0.079), indicating that 23% of the HIV transmission events from HIV-infected
women may be attributable to TV infection when 22% of women are co-infected with TV.
Conclusions—The data suggest the need for improved diagnosis of TV infection and suggest
that HIV-infected women in medical care may be appropriate targets for enhanced testing and
treatment.
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INTRODUCTION
The southeastern (SE) region of the USA carries an excess burden of the 55,000 HIV
diagnoses and the nearly 19 million sexually transmitted infections (STIs) occurring
annually1, 2. In 2007, 46% of new AIDS diagnoses were in the SE USA; 40% of the people
living with AIDS; and of the 14000 individuals who died of AIDS in 2007, 50% lived in the
SE 3. Trichomoniasis is the most common curable STI among young, sexually active
women worldwide and an estimated 174 million new cases of TV occur globally each year 4
and highly prevalent in African-Americans, a population carrying the burden of HIV in the
SE USA.5 In the US, 3.1% of the adult population is estimated to be infected with TV6,
however detailed epidemiology is limited as TV is not a reportable infection.
Studies now suggest that trichomoniasis, caused by the protozoan parasite, Trichomonas
vaginalis (TV), also plays an important but under-appreciated role in increasing the sexual
acquisition and transmission of HIV 7–13. The mechanisms by which TV may increase HIV
acquisition include: 1) elicitation of an inflammatory response of vaginal, exocervix and
urethral epithelia with recruitment of CD4 lymphocytes, macrophages and micro-
hemorrhages, potentially compromising the mechanical barrier; 2) association with
increased HIV viral load in genital secretions; 3) degradation of secretory leukocyte protease
inhibitors; and 4) enhanced susceptibility to bacterial vaginosis or colonization with other
abnormal vaginal flora, which in turn increases the risk of HIV acquisition12.
Sexual partners exchange TV readily. One cross-sectional study found 71% of male partners
of infected women were infected when assessed at a single time point and several other
populations report a high prevalence of TV14, 15. Therefore it has been hypothesized that TV
infection plays a significant role in HIV transmission at a global or national or level even if
the effect on an individual’s risk is small4.
TV remains a highly prevalent STI among HIV-infected patients even when patients are in
care for years16. The effect of TV on HIV transmission from HIV co-infected people is less
well defined. HIV acquisition was unchanged in the presence of TV infection in some
studies while in others, it was increased by 1.2 to 4.8-fold among cohorts of African and
African-American women infected with TV8–11. HIV shedding in semen was 19-times
higher among 5 men with TV-associated urethritis and four times higher in women with TV
compared with TV uninfected men and women with HIV 17, 18. Three studies have looked at
the effect of TV infection on HIV transmission and the effect size ranged from no effect to
an increased odds of 1.84 10, 19, 20. One study used presence or absence of discharge to
detect STIs including TV (no effect found). Gray and colleagues reported an effect size of
1.5 but combined TV with other vaginal infections. Only Quinn et al. reported the effect
(1.8) of TV independently by controlling for other STIs in multivariate analyses.
HIV transmission is a complex event that depends on many inter-related behaviors,
including the presence or absence of STIs. Knowledge of population level HIV transmission
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can be enhanced less expensively by using individual level data in mathematical modeling.
We examined clinical, demographic and behavioral characteristics associated with TV
infection and used this information to conduct mathematical modeling to estimate the
number of transmitted HIV infections attributable to TV among a cohort of HIV-infected
patients receiving medical care in North Carolina.
MATERIALS AND METHODS
Study site and participants
The STI sub-study was part of two HIV prevention studies: 1) Prevention with Positives
Special Project of National Significance (SPNS)21 (May 7, 2004, to May 31, 2006) and 2)
CDC Positive STEPS (CDC)22 (May 19, 2004, to October 13, 2004) conducted at the
University of North Carolina – Chapel Hill with Institutional Review Board approval. The
UNC Healthcare Infectious Diseases clinic is a public academic medical clinic and was the
site of the studies. SPNS eligibility requirements were: ≥ 18 years of age, planning to
receive care at the clinic for one year, English-speaking, treated at the clinic at least once
previously, and currently sexually active or injecting drugs. This study compared provider
based prevention counseling to the combination of specialist delivered MI prevention
sessions in addition to the provider-delivered prevention standard of care. The CDC study
eligibility required the subject to have been diagnosed HIV-positive for 6 months or more
prior to enrollment in addition to the same criteria use for SPNS enrollment. The CDC study
evaluated the implementation of provided-delivered prevention counseling in a quasi-
experimental pre-post intervention design 23. Subjects who completed the CDC study were
allowed to enroll in the SPNS study after a 3-month washout period.
Audio-Computer Assisted Self-Interview (ACASI) programs at baseline and two (2) 6-
month follow-up time points were used in both studies to record socioeconomic,
psychosocial, clinical, and sex behavioral characteristics21, 22. The CDC study collected
sexual behavior (number of sex acts, vaginal and anal sex acts, use of condoms and HIV
status of partners) over the prior 3 months and the SPNS study collected the same sexual
behavior over the prior 6 months. In other respects the data were similar. Chart abstraction
was performed for information on zip codes, CD4, HIV RNA, and STI lab tests, medical
visits, and antiretroviral therapy (ART) use. Interview data collected during participation in
the CDC study was used when subjects had participated in both studies. Urine samples were
provided at baseline and follow-up (6 months and 13 months). Zip codes were used to
approximate rural-urban commuting areas (RUCA), a census-tract based classification of a
residence’s rural urban status.24 Categories used: Urban: RUCA 1–3; Large town: RUCA 4–
6; Small town: RUCA 7–9; Rural: RUCA 10.
Conversion of 3-month sexual behavior data
The only key difference between data collected in the two studies was that the referent time
period for sexual behavior was 3 months for the CDC study and 6 months for the SPNS
study. The dually enrolled subjects had both 3 month and 6 month sexual behavior data to
use for validation of our method of converting 3 to 6 month data. To estimate CDC
participants’ 6-month sexual behavior, the number of sex acts in 3 months was multiplied by
two. To estimate the number of sex partners, main partnerships were assumed to remain
constant (1 main partner in 3 months is still 1 main partner in 6 months) but casual partners
were assumed to increase across time (2 casual partners in 3 months but 4 casual partners in
6 months) 25. Participants were considered to have one main partner if they were married, in
a committed relationship, in a domestic partnership or lived with a sex partner or spouse.
This main partner was subtracted from the total number of sex partners to determine the
number of casual partners. Partner numbers for participants with {(n6mo) = 1 + 2(n3mo−1)}
Quinlivan et al. Page 3













or without {(n6mo) = 2(n3mo)} a main partner were estimated for 6 months. This equation
was validated by comparing its results with actual data from 76 participants who enrolled in
both studies; the equation was found to slightly underestimate 6-month partner number
(estimating 0.91 partners for each actual partner) but did not alter the predicted partner
number for any individual.
Laboratory detection and treatment of STIs
Nucleic acid amplification tests (NAATs) for the detection of Neisseria gonorrhoeae (NG),
Chlamydia trachomatis (CT), and TV were performed on first-catch urine samples collected
at baseline and each of two (2) 6 month follow-up times. For CT/NG testing, we used Gen-
Probe APTIMA Combo 2 according to the manufacturer’s instructions. For TV testing, we
used real-time PCR (September 28, 2004 to August 15, 2006)26 or Gen-Probe TV Analyte
Specific Reagents (ASR, after August 15th 2006)27. Published sensitivities and specificities
of the TV assays are as follows: 90.1% and 100%, respectively, for detection of TV in urine
by real-time PCR.26; 98.2% and 98.0%, respectively, for detection of TV in vaginal swabs
by this ASR27; and 95.2% and 98.9%, respectively, for detection of TV in urine by FDA-
approved NAAT analogous to the ASR assay 28.
Statistical analyses
Predictors of TV Diagnosis—Prevalence and incidence estimates were determined from
the baseline and the follow-up (6m and 13m) STI results, respectively. Participants were
considered as TV-infected if TV was detected at any time point. Bivariate analyses
determined the associations of hypothesized predictor variables 22 with TV diagnosis using
chi square χ2 and Wilcoxon rank sum tests. Variables for multivariable logistic regression
(performed with and without gender) were selected based on the bivariate analysis and
importance in the literature, while avoiding collinear elements.
Estimation of HIV transmission attributable to TV—Analyses to estimate the HIV
transmission attributable to the STI study participants and the effect of TV infection on
transmission were conducted by estimating the potential number of new HIV infections in 6
months. To create a mathematical model, we adapted an equation used previously21, 29 that
calculates, based on self-reported risk behavior and other factors, for each study participant,
the probability, Pi, that he or she would transmit HIV to a sexual partner. The probability of
HIV transmission depends upon the number and type of sex acts in 6 months (superscripts a,
b, c, d, n, [unprotected]; A, B, C, D, N), [protected], condom effectiveness (β), probability
that an unknown partner is HIV infected (λ), HIV viral load (μ) and TV infection (TV). The
number of unprotected sex acts in 6 months is represented by lower case superscripts a, b, c,
d and n (a: insertive vaginal, b: receptive vaginal, c: insertive anal and d: receptive anal and
n: total acts). Protected acts are denoted by the corresponding upper case superscript (A, B,
C, D, N). Condom efficacy (β) (when used) was estimated as 90% for the base estimate and
80–100% for sensitivity analyses. The probability that a partner of unknown sero-status is
actually HIV infected (λ) is also included in the model. The addition of TV infection effect
(TV) and the actual HIV viral load in blood plasma (μ) (instead of a 50% reduction in risk if
anti-retrovirals were being used) were adaptations to the previously published model.
The effect of TV on HIV transmission is unknown. A meta-analysis of risk estimated the TV
effect on HIV acquisition as 1.5 in 2001 and ranged from 0 to 4.8 in subsequent studies of
African and African American women 11. The effect on HIV transmission was determined
independently in one study, reported as 1.8 10. Consequently, the effect of TV on per-act
transmission probability was determined by multiplying α by the effects of TV infection
(1.8). The TV effect was estimated as 1.0 (no effect) to 2.0 in a sensitivity analysis.
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The λ parameter denotes the probability that the partner was already infected with HIV and
λ was set as 1 for HIV-positive partners, 0 for HIV-negative partners, 8.47% for HIV
unknown status male partners of men30; 0.72% for HIV unknown status male partners of
women and 0.22% for HIV unknown status female partners of men31. The range for the
sensitivity analysis for the probability of prior infection was estimated as 50% (1/2) of the
prevalence reported, to 200% (2-fold) the predicted prevalence.
The associated per act transmission probabilities (α) were indicated as αa, αb, αc, and αd
(0.0006 for unprotected receptive anal and vaginal intercourse, 0.001 for unprotected
insertive vaginal intercourse, and 0.02 for unprotected insertive anal intercourse)21. The
terms “receptive and insertive” refer to the role of the study subject in the sex act. The
standard per act transmission probabilities (α) (see below) were estimated from participants
who were not on anti-retroviral therapy and typically have a HIV RNA level of 4.5 log10
copies/ml. 10, 32.
The μ parameter represented the predicted change in transmissibility based on the
participants’ actual viral load (the majority while on antiretroviral therapy) compared with
an untreated population average μ/(actual log10 HIV RNA − log104.5) and was estimated as
2.45 9. Most (75%) of the participants were on antiretroviral therapy and viral loads were
lower than the base level of 4.5 log10 copies/ml. The fold change effect per log viral load (μ)
reduced the impact of the viral load on transmissibility if the subject’s viral load was less
than the untreated average. In this case, a higher fold-change effect (3.26) will produce a
lower estimate of transmission had a greater reduction in the effect of the viral load
compared with smaller fold-change effect size (1.86).
The following equation represents the transmission probability. Pi = (1 − λ) {1 −
(1−(1−μ)αaTV)a/n (1 − (1 − μ)αbTV)b/n(1 − (1 − μ)αcTV)c/n (1 − (1 −
μ)αdTV)d/n(1−(1−μ)αaTV)A/n (1 − (1 − μ)αb(1−β)TV)B/n (1 − (1 − μ)αc(1−β)TV)C/n(1 − (1 −
μ)αd(1−β)TV)D/n}. Using the probability (Pi) and the number of partners, the number of new
HIV infections from each study participant was predicted as the sum of new infections
predicted for each of four partner types (HIV-negative male, HIV-unknown status male,
HIV-negative female, HIV-unknown status female).
RESULTS
Participants
Participants in two prevention with positive studies (CDC = 186, SPNS =234), were offered
participation in an STI screening sub-study. Of the 186 CDC subjects, 140 agreed to
participate in the sub-study. Of the 234 SPNS subjects, 223 agreed to participate but 76 of
these individuals had previously participated in the CDC sub-study leaving 147 new subjects
enrolled from the SPSN study and a total of 287 unique STI sub-study subjects. One
participant failed to complete the ACASI. Four urine samples contained inhibitors of
amplification, leaving a total of 541 usable urine samples from 285 active participants.
The 285 participants included in the STI sub-study sample did not differ from those in the
total SPNS/CDC study sample in age, sex, or race/ethnicity (all p > 0.05). The mean age was
42 years; 63% were men, 66% were African American, 28% were white, 61% had 12 years
of education or less, 56% had an annual income of <$10,000 and 61% were unemployed.
The study population (37% female, 66% AA, 28% white non-Hispanic, 6% other race/
ethnicity; 31% MSM exposure, 48% heterosexual exposure to HIV, and 63% aged over 40)
was similar to the HIV population in North Carolina (28% women, 66% AA, 27% white
non-Hispanic, 7% other, 33% MSM, 25% heterosexual exposure to HIV, and 53% aged over
40) except that women and older ages were over represented in the sub-study. The
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difference between the 48% heterosexuals in the sub-study and 25% heterosexuals in NC is
due to a large category of “no reported risk” in the NC data.
STI Prevalence and Incidence
A total of 541 urine samples were collected from 285 patients and analyzed for NG, CT, and
TV (Figure 1). TV was detected in 34 urine samples from 28 individuals (5 heterosexual
men, 0 MSM and 23 women). TV was detected at baseline in 7.4% (n = 21/285). New TV
(incident) infections were found in 3% of patients at the first (6m) and 2% at the second
(13m) follow-up (5/174 and 2/86). Also TV was present at follow-up secondary to failure to
receive treatment (n=2) and relapse or re-infection (n=4). CT (3/285 at baseline; 2/174 at 1st
follow-up; 0/86 at 2nd follow-up) and NG (2/285 at baseline; none at either follow-up) were
rarely detected, and 3 of these 7 patients were co-infected with TV. All patients with TV,
NG or CT were treated. NG and CT infections were reported the NC Division of Public
Health.
Bivariate Analyses
Men were less likely to have TV infection compared to women (Table 1; OR 0.10). Non-
whites were less likely to have TV infection compared to those who were white (OR 0.28).
Participants with higher levels of education or employment were less likely to have TV (OR
0.24; OR 0.24, respectively). Participants with HIV RNA copy numbers ≤ 400 copies/ml
were less likely to have TV infection (OR 0.32). TV infection did vary by type of sexual act
and was strongly associated with all vaginal sex acts (protected and unprotected). Privately
insured participants were less likely to have TV than un-insured or publicly insured patients
(0% vs. 11%). Those living in urban settings had less TV infections than those living in
other settings (7% vs. 13%); and those receiving anti-retroviral medications versus those
who were not (8% vs. 13%), but these differences did not reach statistical significance.
Number of sexual partners (>1 vs. ≤1), alcohol use, and cocaine use were selected because
of associations with risks for STI exposure and unprotected sex behaviors but were not
associated with TV. TV was not associated with CD4 count, time living with HIV, time in
HIV care, overall health status, distance to clinic (data not shown).
HIV Transmission Risk
TV only contributed to the transmission risk for women, as TV was not detected in men who
have sex with men (MSM) and men who have sex with women (MSW) infected with TV
only reported HIV+ partners (Table 3). Using a TV effect size of 1.8, the mathematical
model predicted that 0.062 HIV infections would occur per 100 female HIV participants in
the absence of TV infection and 0.076 HIV infections will occur if TV infection was
prevalent in 22% of the HIV-infected women. HIV infection estimates were 0.062, 0.070
and 0.079 per 100 persons if TV effect sizes 1.0, 1.5 or 2.0 were used, estimating 0%, 14%,
or 28% additional HIV infections. In the base estimate, one-fifth of HIV transmission events
(22.5%) from HIV-infected women participants will be caused by TV infection if TV
remains prevalent in one of five women.
The model for all subjects was not sensitive to the estimated effect of TV infection or the
prevalence of HIV in unknown-status partners reported from the NHANES study (using ½
to 2-fold) 30, 31. However, the model was sensitive to the efficacy of condoms (0.14 – 0.39
per 100 persons using 80% –100% efficacy, +/− 47% change) on the estimate of HIV
infections. The model was also sensitive to the effect size (1.85 to 3.26) of each log10
change in HIV RNA (−13, +25% of the base estimate). Predicted transmission events ranged
from 0.23 per 100 persons with the highest effect size of HIV RNA log change (3.26/(actual
HIV RNA – log104.5)) to 0.33 for the lowest effect size for HIV RNA change (1.85/(actual
HIV RNA – log104.5)). Most of the HIV RNA values were less than the untreated
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population average of log104.5, so a higher effect size produced a larger reduction in
transmission risk.
DISCUSSION
In this study of HIV infected patients in care, we used individual level data to inform an
attributable risk model to describe the effect TV infection may have on HIV transmissibility.
Our model estimates that this range is from 0% to 28% and the base model estimate is that
22% of projected HIV transmissions from women are attributable to TV infections and up to
2% of all HIV transmission in the USA may be related to TV infection. The estimates of
transmission risk in a previous study are approximately 2 to 4-fold higher of that reported
here 21. Two differences in the studies may explain this. First, the number of MSM recruited
was very different (50% vs. 33% in our study). Second, the inclusion of HIV RNA values
varied. In the prior study, the transmission risk was estimated as the standard risk if a person
was receiving antiretroviral therapy, otherwise the transmission risk per act was not adjusted
for the viral load. In our study we adjusted the standard per act transmission risk based on
the actual difference between the subject’s HIV RNA value and the usual untreated
population HIV RNA of 38,000 copies/ml. The model showed that estimates of new HIV
infections were very sensitive to estimates of transmission probabilities associated with viral
load. These results support the recently proposed use of antiretroviral therapy as a
component of an HIV epidemic control strategy 33, 34.
The prevalence of TV infection was far greater than either gonorrheal or chlamydial
infections. This is quite consistent with other studies of TV prevalence in HIV infected
women15 where TV infection is reported in 22% HIV + women when culture or PCR are
used as the detection methods. This difference is likely to be due to the relative sensitivity of
screening for NG and CT compared with traditional methods of screening for TV. Screening
for TV has been a manual assay previously and therefore not as readily used for screening
due to the labor involved and the low sensitivity of microscopy. The prevalence is only 11%
if of wet mounts are used as the detection method. It is also possible that co-infection with
HIV allows a more persistent infection with TV but not NG or CT, explaining the increased
prevalence. NAAT screening for TV was easily implemented and allowed an unrecognized
infection present in more than 10% of the study population to be identified and treated.
TV infection was associated with high HIV viral loads. HIV RNA was higher in TV-
infected participants when examined by either the proportion of participants with less than
400 copies/ml or by mean HIV copies/ml. The association between high viral loads and TV
infection suggests that TV occurs more often in women who are receiving less than adequate
care whether they are new to care or only marginally engaged in care. Improved entry and
retention in care will prevent complications of both TV and HIV infection and avoid the
human and economic costs associated with small, but significant numbers of HIV infections.
Other previously described variables associated with TV infection were vaginal intercourse
low socioeconomic status (low educational attainment, unemployment, lack of private
insurance), and non-white race. Poverty has been consistently associated with TV infection
with a 3-fold increase in TV when income was <1.85 of the federal poverty level6. An
association of TV with educational status has been previously reported, but the 5-fold
increased risk with low education reported in the present study is much greater6. The
association between low educational attainment and TV suggests that inadequate health
literacy may be an important element in the pathway to TV-infection21, 22. In data presented
here, a 3-fold difference in TV prevalence was seen between whites and non-whites.
However, in multivariable analysis, race remained associated with TV infection but not
statistically, perhaps due to sample size or a lack of the racial association within a cohort of
HIV- infected people.
Quinlivan et al. Page 7













The limitations of this study include the self-reported nature of some of the data on which
risk estimates are based, however ACASI technology was used to minimize this. The study
was conducted at one site, which may limit the applicability to other populations. However,
the study site draws patients from a wide geographic area within NC. Demographics of the
STI sub-study are similar to the demographics of the population of newly HIV diagnosed
persons in North Carolina; therefore, the study findings may be applicable to HIV-infected
individuals receiving medical care in North Carolina. Our TV effect estimate of 1.8 is based
on HIV acquisition and limited HIV transmission studies. Although these estimates are
based on limited data and our analyses would be strengthened by more robust data, there are
no other direct data. Moreover, our sensitivity analyses took into account changes in these
assumptions. Third, a conversion method was needed to the estimations we used to convert
three month data to six-month data did not include adjustment for changes in sex behavior
over time or an adjustment the possibility of more than one main partner. However in the
subset of patients who were enrolled in both studies, the calculation was able to predict the
number of partners subjects reported in 6 months by using data from the 3-month data
collection. Fourth, models are based on estimates and not observations. A full discussion of
the strengths and weaknesses of HIV transmission risk models are beyond the scope of this
paper but have been recently discussed 35. Finally, the findings, we report here are only
based on NAAT testing of urine specimens, other detection methods and use of vaginal
specimens instead are likely to influence the findings.
An incidence of TV infection of 2% –3% for HIV-infected women, as reported here,
suggests that more than 5000 new TV infections are occurring in the 290,000 HIV infected
US women annually and potentially contributing to HIV transmission events. Medical care
settings provide the opportunity to address both behavioral and biologic aspects of HIV
transmission. Biological factors, such as TV, that enhance HIV transmission may be
addressed with STI and HIV medical treatments. TV diagnostic assays are appropriate when
clinical history and exam support use of GC and CT testing. However, due to the often-
asymptomatic nature of TV, the limited use of nucleic acid amplification assays, the
insensitivity of cytology, and requirement for a pelvic examination for collection, TV is
frequently overlooked. Examination of the synergistic effects of medical care, education and
counseling, combined with STI treatment and antiretroviral use, should provide more
insights into effective HIV epidemic control.
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HIV infected patients with an undetectable HIV RNA and >12 years of education were
less likely to have Trichomonas vaginalis (TV) infection; theoretical modeling of HIV
transmission suggested that 22% of female-to-male events may be attributable to TV
when the prevalence of TV in HIV-infected women is one in five.
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STI Screening. Urine was screened using nucleic acid amplification tests to detect
Trichomonas vaginalis, Neisseria gonorrhoeae and Chlamydia trachomatis. BL= baseline; F/
u = follow-up.
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TABLE 1
Characteristics of Patients With and Without Trichomonas vaginalis Infection
T. vaginalis (+) OR 95% CI Probability
N/All in Category (%) [chi]2
Age
Age [ltequ] 40 y 15/180 (14) REF
Age [mt] 40 y 13/105 (7) 0.47 0.21–1.02 0.0533
Gender
Women 23/106 (22) REF
Men 5/179 (3) 0.10 0.04–0.28 [lt]0.0001
Race/ethnicity
AA, Hispanic, other 25/205 (12) REF
White, non-Hispanics 3/80 (4) 0.28 0.08–0.96 0.0314
HIV exposure
Heterosexual 22/138 (16) REF
MSM + MSM/IDU 0/87 (0) NA — NA
IDU + other 6/60 (10) 0.59 0.22–1.53 0.0005a
Education
12 y or less 24/175 (14) REF
13 y or more 4/110 (4) 0.24 0.08–0.70 0.0054
Income
[lt]$10,000 18/143 (13) REF
$10–20,000 4/56 (7) 0.53 0.17–1.65 0.01211
[mt]$20,000 0/58 (0) NA — NA
Employment
Unemployed 24/175 (14) REF
All others 4/110 (4) 0.24 0.08–0.70 0.0054
Insurance
Public or none 26/213 (11) REF
Private insurance 0/37 (0) N.A. NA NA
Rurality
Rural 2/26 (8) REF
Small town 11/72 (15) 2.16 0.45–10.49
Large town 5/44 (11) 1.54 0.28–8.56
Urban 10/143 (7) 0.90 0.19–4.38 0.2656
Current ART
No 10/71 (14) REF
Yes 17/211 (8) 0.53 0.23–1.23 0.1354
HIV RNAb
HIV RNA [mt] 400 19/122 (16) REF
HIV RNA [ltequ]400 9/162 (6) 0.32 0.14–0.73 0.0051
CD4 countc
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T. vaginalis (+) OR 95% CI Probability
N/All in Category (%) [chi]2
CD4 count [mt]350 18/166 (11) REF
CD4 count [lt]350 10/115 (9) 0.78 0.35–1.76 0.5552
Sexual group
Women 23/106 (22) REF
MSM + MSM/W 0/93 (0) NA NA NA
MSW 5/86 (6) 0.22 0.08–0.61 [lt]0.0001a
Relationship
No main partner 20/166 (12) REF
<ems>Main partner 8/119 (7) 0.53 0.22–1.24 0.1363
Partners
2 or more 7/72 (10) REF
0 or 1 19/199 (10) 0.99 0.39–2.44 0.9656
Alcohol binges
Any binges 9/86 (9) REF
No binges 17/183 (9) 0.99 0.43–2.31 0.9814
Cocaine use
Any use 7/49 (14) REF
No use 20/229 (9) 0.57 0.23–1.44 0.2336
Note 2. a = Monte Carlo method; b = copies/mL; c = cells/mm3;; d = years. B = binge alcohol use is more than 4 drinks/d; c = crack or powder
cocaine; d = acts/6 mo; e = sexual behaviors = means acts/6 m.
ART indicates antiretroviral therapy; CI, confidence interval; IDU, injection drug use; MSM, men with male partners; MSM/W, men with male
and female sexual partners; MSW, men with female sexual partners; NA, not applicable; T, Trichomonas; UAVI, unprotected anal or vaginal sex;
UVI, unprotected vaginal sex.
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TABLE 2
Trichomonas vaginalis (TV) Infection and Sexual Behaviors
TV([minus]) TV(+) Wilcoxon Rank Sum
Sex partners
No. partners in 6 mo, mean 2.44 1.52 —
Sex behaviors (sex acts in 6 mo, mean)
Anal or vaginal sex 19.15 53.42 —
Vaginal sex 13.79 53.04 0.0009
Anal or vaginal sex, unprotected 9.57 42.50 0.0909
Vaginal sex, unprotected 6.99 42.27 0.0012
All (n) 257 28
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